How Does Lam Research Corporation (LRCX) Stack Up Right Now?

Lam Research Corporation (LRCX) is an interesting player in the Technology space, with a focus on Semiconductor Equipment & Materials. The stock has been active on the tape, currently trading at $184.07, down from yesterday’s close by -0.79%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.

Fundamental Analysis

Lam Research Corporation (LRCX) currently trades with a market capitalization of $30.05 Billion. That value represents a market adjusting for revenues that have been growing by 51.81 % on a quarterly year/year basis as of the company’s last quarterly report.

You can get a sense of how sustainable that is by a levered free cash flow of $2.24 Billion over the past twelve months. Generally speaking, earnings are expected to grow in coming quarters. Analysts are forecasting earnings of $3.68 on a per share basis this quarter. Perhaps, that suggests something about why 0.88% of the outstanding share supply is held by institutional investors.

Technical Analysis

We’ve taken a serious look at this stock from a fundamental perspective, but the tale of the tape may offer more hints about what lies under the surface. Looking at the stock’s movement on the chart, Lam Research Corporation recorded a 52-week high of $219.70. It is now trading 35.63% off that level. The stock is trading $198.72 its 50-day moving average by 14.65%. The stock carved out a 52-week low down at $105.30.

In recent action, Lam Research Corporation (LRCX) has made a move of -4.29% over the past month, which has come on Strong relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 19.03, and it’s gotten there by action that has been more volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 8.15% with $161.44 Million sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of LRCX.

Previous articleChecking the Overall Picture for Bristol-Myers Squibb Company (BMY)
Next articleTaking a Fresh Look at Danaher Corporation (DHR)